Accès ouvert
2024
conference-abstract
OpenAlex
Stefan Verheye, Bas Hamer, Valeria Paradies, Pim A.L. Tonino et autres
be, nl
(code pays fourni par la source)
Accès ouvert
2024
conference-abstract
OpenAlex
Johan Bennett, Bas Hamer, Valeria Paradies, Pim A.L. Tonino et autres
be, nl
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Kausik Kumar Ray, Carlos Aguíar, Marcello Arca, Derek Connolly et autres
AIMS: To assess whether implementation of the 2019 European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) dyslipidaemia guidelines observed between 2020 and 2021 improved between 2021 and 2022 in the SANTORINI study. METHODS AND RESULTS: Patients with high or very high cardiovascular …
gb, pt, it, fr, se, de, ch, be, fi, at, nl, nz
(code pays fourni par la source)
2022
article
OpenAlex
A Omar Khader, S Van Der Brug, Anho H Liem, Bas Hamer et autres
Abstract Background Hyperlipidemia is an important risk factor for developing cardiovascular disease. Lowering LDL-C reduces the risk for coronary heart disease: the longer LDL-C remains low, the better. We studied the effect of implementing a guideline based, stepwise approach of lipid-modifying therapy …
nl
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Kuniaki Takahashi, Patrick W.J.C. Serruys, Norihiro Kogame, Paweł Eugeniusz Buszman et autres
Background: Numerous randomized clinical trials have demonstrated the superiority of thin-strut biodegradable polymer second-generation drug-eluting stent to the first-generation drug-eluting stent and the noninferiority to the thin-strut second-generation permanent polymer drug-eluting stent. Data on long-term clinical outcomes with a novel ultrathin drug-eluting …
nl, ie, pl, de
(code pays fourni par la source)
2017
article
OpenAlex
Robbert J. de Winter, Yuki Katagiri, Taku Asano, Krzysztof P. Milewski et autres
nl, pl, de, fr, ie, be, us, gb
(code pays fourni par la source)
Accès ouvert
2016
article
OpenAlex
Sean D. Pokorney, Jonathan Paul Piccini, Susanna R. Stevens, Manesh R. Patel et autres
BACKGROUND: Atrial fibrillation is associated with higher mortality. Identification of causes of death and contemporary risk factors for all-cause mortality may guide interventions. METHODS AND RESULTS: In the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for …
us, de, au, gb
(code pays fourni par la source)
Accès ouvert
2010
article
OpenAlex
Pieter R. Stella, George Pavlakis, Piergiuseppe Agostoni, Hendrik M. Nathoe et autres
nl
(code pays fourni par la source)
2009
article
OpenAlex
Niels W.C.J. van de Donk, Yves G.C.J. America, PIERRE M. J. ZELISSEN, Bas Hamer
We report on a 73-year-old man with a toxic multinodular goitre, which was treated with radioiodine therapy (I-131) without pretreatment with an antithyroid drug. Four weeks later he presented with rapidly progressive dyspnoea and a significant increase in free thyroxin. The electrocardiogram …
nl
(code pays fourni par la source)
Accès ouvert
2007
article
OpenAlex
Fuli Man, Pieter R. Stella, Hendrik M. Nathoe, Hans Kirkels et autres
nl
(code pays fourni par la source)
2007
article
OpenAlex
Georgios Pavlakis, Frits de Man, Bas Hamer, Pieter A. Doevendans et autres
AIMS: The goal of this study was to clinically evaluate the effectiveness of a new coronary stenting approach for bifurcation lesions designed to provide adequate main and side-branch ostial scaffolding and provide a simplified technique. METHODS AND RESULTS: The technique was used …
nl
(code pays fourni par la source)
2002
article
OpenAlex
Elliott Marshall Antman, Hans W. Louwerenburg, Hubert F. Baars, Jan C. Wesdorp et autres
BACKGROUND: ENTIRE-TIMI 23 evaluated enoxaparin with full-dose tenecteplase (TNK) and half-dose TNK plus abciximab. METHODS AND RESULTS: Patients (n=483) with ST-elevation MI presenting <6 hours from symptom onset were randomized to full-dose TNK and either unfractionated heparin (UFH) (bolus 60 U/kg; infusion …
be, nl, fr
(code pays fourni par la source)